[Corrigendum] Azurocidin 1 inhibits the aberrant proliferation of triplenegative breast cancer through the regulation of pyroptosis.
Oncol Rep
; 51(3)2024 Mar.
Article
en En
| MEDLINE
| ID: mdl-38275105
ABSTRACT
Following the publication of the above article, the authors drew to our attention that they had made a couple of inadvertent errors in assembling Figs. 4 and 5; first, for the BT549 cell line, the data shown for the Procaspase1/Cleaved caspase1 in Fig. 5 and the GSDMDF/GSDMDN data in Fig. 4B were identical, and had been derived from the same original source; secondly, in Fig. 4A, the data shown correctly for the GSDMD BT549 cell line had also inadvertently been included in this figure to represent the MDAMB231 cell line. The revised and corrected versions of Figs. 4 and 5, showing the correct western blotting data for the GSDMD experiment in Fig. 4A and the Procaspase1/Cleaved caspase1 data for the BT549 cell line in Fig. 5, are shown in the next two pages. The authors regret that these errors in the assembly of Figs. 4 and 5 went unnoticed before the article was published, and thank the Editor of Oncology Reports for granting them the opportunity to publish this corrigendum. All the authors agree with the publication of this corrigendum; furthermore, they apologize to the readership of the journal for any inconvenience caused.[Oncology Reports 50 188, 2023; DOI 10.3892/or.2023.8625].
Texto completo:
1
Base de datos:
MEDLINE
Idioma:
En
Revista:
Oncol Rep
Asunto de la revista:
NEOPLASIAS
Año:
2024
Tipo del documento:
Article